ALXO Stock Analysis: Buy, Sell, or Hold?
ALXO - ALX Oncology Holdings Inc. Common Stock
$1.94
-0.01 (-0.51%)
▼
5d:
-4.43%
30d:
-5.83%
90d:
+14.12%
BUY
HIGH Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 11, 2026
7d
Get Alerted When ALXO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ALXO shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: ALXO shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: ALXO is currently trading at $1.94, which is considered slightly low relative to its 30-day fair value range of $1.93 to $2.17.
Technical Outlook: Technically, ALXO is in a strong uptrend. Immediate support is located at $1.85, while resistance sits at $2.13.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.60 (+137.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ALXO is in a strong uptrend. Immediate support is located at $1.85, while resistance sits at $2.13.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.60 (+137.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.93 -
$2.17
Company Quality Score
57/100
(HOLD)
Options IV Signal
49th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
80.0%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 49th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 137.1% below Wall St target ($4.60)
Trading Range Analysis
30-Day Trading Range
$1.93 -
$2.17
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
±$0.43
(22.1%)
Support & Resistance Levels
Support Level
$1.85
Resistance Level
$2.13
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.61
Wall Street Target
$4.60
(+137.1%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: August 03, 2026 1:50 AM ET
Data refreshes hourly during market hours. Next update: 2:50 AM
Data refreshes hourly during market hours. Next update: 2:50 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALXO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Jason Lettmann
SELL
12311 shares
2026-03-19
Shelly Pinto
SELL
903 shares
2026-03-19
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 53 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$282 | 54 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$33 | 60 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$105 | 56 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$123 | 59 HOLD |
Advanced ALXO Option Strategies
Professional options setups generated by AI based on today's ALXO price and gamma walls.
